genOway offers industry scientists immediate access to EUCOMM conditional KO mouse models
genOway guarantees freedom to operate (FTO) and offers important gains in conditional knockout development time...
Cancer research departments need to think beyond checkpoint inhibitors
Cancer immunotherapy research departments need to break their obsession with the latest flavour of the...
Provepharm and Dr Franz Kohler Chemie partner to provide Methylthioninium chloride Proveblue solution for...
Proveblue(R) is the methylthioninium chloride or Methylene Blue active substance patented by Provepharm, compliant with...
Ferrer initiates second phase III clinical study for Ozenoxacin in adult and paediatric patients...
Ozenoxacin, a novel bactericidal non-fluorinated quinolone that successfully completed a first phase III clinical trial...
State-owned British research institute fund Clinical trial of Airsonett – an innovative Swedish...
There are 5 million persons suffering from asthma in Great Britain and despite medication, half...
Point of Care Set to Boom in Coming Years; Driving Forward Quality and ...
The global market for Point of Care diagnostics is set to sharply increase by 2018...
The Orphan Drugs Market is set to Rise as a Result of Pharma Companies...
As of January 2014, the EMA lifted the restriction on providing fee reductions to large...
Chemistry: Provence Technologies acquires Synprosis
Provence Technologies acquires SynprosisThe acquisition strengthens Provence Technologies’ expertise in its core business of therapeutic...
Only one week left before BIOVISION, June 5 and 6 Cite Internationale in Lyon,...
Disruptive Innovation – Health – Funding | Immunotherapies – Healthy AgeingOnly one week left to...
Orphan Drugs
The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now...
